HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Respiratory effects of low and high doses of fentanyl in control and β-arrestin 2-deficient mice.

Abstract
We have investigated the potential acute desensitizing role of the β arrestin 2 (β-arr2) pathway on the ventilatory depression produced by levels of fentanyl ranging from analgesic to life-threatening (0.1 to 60 mg/kg ip) in control and β-arr2-deficient nonsedated mice. Fentanyl at doses of 0.1, 0.5, and 1 mg/kg ip-corresponding to the doses previously used to study the role of β-arr2 pathway-decreased ventilation, but along the V̇e/V̇co2 relationship established in baseline conditions. This reduction in ventilation was therefore indistinguishable from the decrease in breathing during the periods of spontaneous immobility. Above 1.5 mg/kg, however, ventilation was depressed out of proportion of the changes in metabolic rate, suggesting a specific depression of the drive to breathe. The ventilatory responses were similar between the two groups. At high doses of fentanyl (60 mg/kg ip) 1 out of 20 control mice died by apnea versus 8 out of 20 β-arr2-deficient mice (P = 0.008). In the surviving mice, ventilation was however identical in both groups. The ventilatory effects of fentanyl in β-arr2-deficient mice, reported in the literature, are primarily mediated by the "indirect" effects of sedation/hypometabolism on breathing control. There was an excess mortality at very high doses of fentanyl in the β-arr2-deficient mice, mechanisms of which are still open to question, as the capacity of maintaining a rhythmic, although profoundly depressed, breathing activity remains similar in all of the surviving control and β-arr2-deficient mice.NEW & NOTEWORTHY When life-threatening doses of fentanyl are used in mice, the β-arrestin 2 pathway appears to play a critical role in the recovery from opioid overdose. This observation calls into question the use of G protein-biased μ-opioid receptor agonists, as a strategy for safer opioid analgesic drugs.
AuthorsPhilippe Haouzi, Marissa McCann, Nicole Tubbs
JournalJournal of neurophysiology (J Neurophysiol) Vol. 125 Issue 4 Pg. 1396-1407 (04 01 2021) ISSN: 1522-1598 [Electronic] United States
PMID33656934 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Analgesics, Opioid
  • Arrb2 protein, mouse
  • beta-Arrestin 2
  • Fentanyl
Topics
  • Analgesics, Opioid (administration & dosage, adverse effects, pharmacology)
  • Animals
  • Apnea (chemically induced)
  • Behavior, Animal (drug effects)
  • Disease Models, Animal
  • Female
  • Fentanyl (administration & dosage, adverse effects, pharmacology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Opiate Overdose (metabolism)
  • Respiration (drug effects)
  • Signal Transduction (drug effects)
  • beta-Arrestin 2 (deficiency, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: